Clovis Oncology, Inc. Accretion Expense
Clovis Oncology, Inc. reported Accretion Expense of $783.00 thousand for the 3-month period ending 2015-09-30, per its 10-Q filed 2015-11-06.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AccretionExpense · last filed 2015-11-06
- Clovis Oncology, Inc. accretion expense for the quarter ending 2015-09-30 was $783.00K, a 11.82% decline year-over-year.
- Clovis Oncology, Inc. accretion expense for the quarter ending 2015-06-30 was $764.00K, a 11.27% decline year-over-year.
- Clovis Oncology, Inc. accretion expense for the quarter ending 2015-03-31 was $724.00K, a 11.92% decline year-over-year.
- Clovis Oncology, Inc. accretion expense for the quarter ending 2014-12-31 was -$1.86M, a 560.25% decline year-over-year.
- Clovis Oncology, Inc. accretion expense for fiscal 2014 was $707.00K, a 74.57% increase from fiscal 2013.
- Clovis Oncology, Inc. accretion expense for fiscal 2013 was $405.00K.
| Period end | Accretion Expense 3 month | Accretion Expense 6 month | Accretion Expense 9 month | Accretion Expense 12 month | Accretion Expense 56 month |
|---|---|---|---|---|---|
| 2015-09-30 | $783.00K 10-Q · filed 2015-11-06 | $1.55M derived: sum of 2 quarters · filed 2015-11-06 | $2.27M 10-Q · filed 2015-11-06 | $407.00K derived: sum of 4 quarters · filed 2015-11-06 | |
| 2015-06-30 | $764.00K 10-Q · filed 2015-08-07 | $1.49M 10-Q · filed 2015-08-07 | -$376.00K derived: sum of 3 quarters · filed 2015-08-07 | $512.00K derived: sum of 4 quarters · filed 2015-11-06 | |
| 2015-03-31 | $724.00K 10-Q · filed 2015-05-08 | -$1.14M derived: sum of 2 quarters · filed 2015-05-08 | -$252.00K derived: sum of 3 quarters · filed 2015-11-06 | $609.00K derived: sum of 4 quarters · filed 2015-11-06 | |
| 2014-12-31 | -$1.86M 10-K · filed 2015-02-27 | -$976.00K derived: sum of 2 quarters · filed 2015-11-06 | -$115.00K derived: sum of 3 quarters · filed 2015-11-06 | $707.00K 10-K · filed 2015-02-27 | |
| 2014-09-30 | $888.00K 10-Q · filed 2015-11-06 | $1.75M derived: sum of 2 quarters · filed 2015-11-06 | $2.57M 10-Q · filed 2015-11-06 | $2.98M derived: sum of 4 quarters · filed 2015-11-06 | |
| 2014-06-30 | $861.00K 10-Q · filed 2015-08-07 | $1.68M 10-Q · filed 2015-08-07 | $2.09M derived: sum of 3 quarters · filed 2015-08-07 | ||
| 2014-03-31 | $822.00K 10-Q · filed 2015-05-08 | $1.23M derived: sum of 2 quarters · filed 2015-05-08 | |||
| 2013-12-31 | $405.00K 10-K · filed 2015-02-27 | $405.00K 10-K · filed 2015-02-27 | $405.00K 10-K · filed 2014-02-28 |